These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 26810254)

  • 1. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests.
    Vickers AJ; Van Calster B; Steyerberg EW
    BMJ; 2016 Jan; 352():i6. PubMed ID: 26810254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.
    Vickers AJ; Cronin AM; Elkin EB; Gonen M
    BMC Med Inform Decis Mak; 2008 Nov; 8():53. PubMed ID: 19036144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Diagnostic Tests.
    Barrett BJ; Fardy JM
    Methods Mol Biol; 2021; 2249():319-333. PubMed ID: 33871852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enhancement of ROC curves made them clinically relevant for diagnostic-test comparison and optimal-threshold determination.
    Subtil F; Rabilloud M
    J Clin Epidemiol; 2015 Jul; 68(7):752-9. PubMed ID: 25660050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian bootstrap estimation of ROC curve.
    Gu J; Ghosal S; Roy A
    Stat Med; 2008 Nov; 27(26):5407-20. PubMed ID: 18613217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of outcome.
    Conrad SA; McLarty JW
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4 Suppl 1):S42-50. PubMed ID: 19891287
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic tests and ROC curves analysis].
    D'Arrigo G; Provenzano F; Torino C; Zoccali C; Tripepi G
    G Ital Nefrol; 2011; 28(6):642-7. PubMed ID: 22167615
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of semiparametric, parametric, and nonparametric ROC analysis for continuous diagnostic tests using a simulation study and acute coronary syndrome data.
    Colak E; Mutlu F; Bal C; Oner S; Ozdamar K; Gok B; Cavusoglu Y
    Comput Math Methods Med; 2012; 2012():698320. PubMed ID: 22844346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric estimation of ROC curves in the absence of a gold standard.
    Zhou XH; Castelluccio P; Zhou C
    Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients.
    Gamil M; Alboraie M; El-Sayed M; Elsharkawy A; Asem N; Elbaz T; Mohey M; Abbas B; Mehrez M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1080-1086. PubMed ID: 29315641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies beyond the German Drug Law. Studies for evaluating diagnostic tests].
    Abel U; Jensen K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):425-32. PubMed ID: 19326057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the diagnostic accuracy of a sequence of tests.
    Thompson ML
    Biostatistics; 2003 Jul; 4(3):341-51. PubMed ID: 12925502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive and diagnostic accuracy of vascular endothelial growth factor and pentraxin-3 in severe dengue.
    Low GKK; Gan SC; Zainal N; Naidu KD; Amin-Nordin S; Khoo CS; Ridzuan MI; Said RM; Mansor MM; Zailani MH; Chee HY; Lim SJ; Suppiah J; Appu S; Ismail I; Zin T; Te KK; Hatta NM
    Pathog Glob Health; 2018 Sep; 112(6):334-341. PubMed ID: 30246621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key concepts and limitations of statistical methods for evaluating biomarkers of kidney disease.
    Parikh CR; Thiessen-Philbrook H
    J Am Soc Nephrol; 2014 Aug; 25(8):1621-9. PubMed ID: 24790177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology of diagnostic tests in hepatology.
    Christensen E
    Ann Hepatol; 2009; 8(3):177-83. PubMed ID: 19841495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters.
    Chunming L; Jianhui S; Hongguang Z; Chunwu Q; Xiaoyun H; Lijun Y; Xuejun Y
    Turk J Gastroenterol; 2015 Sep; 26(5):408-16. PubMed ID: 26215061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian meta-analysis of diagnostic tests allowing for imperfect reference standards.
    Menten J; Boelaert M; Lesaffre E
    Stat Med; 2013 Dec; 32(30):5398-413. PubMed ID: 24003003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.